Delivery Order SPE2DR25D1002-SPE2DR26FGM3Z
Award Date 1/6/26
Potential Completion Date 1/7/26
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The order, valued at $1,220.18 with a firm fixed price structure, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of January 6, 2026. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,702.52 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by January 7, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This $3,552.68 firm fixed-price delivery order, which is not set-aside restricted, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $5,582.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is set to be completed by August 26, 2025, just one day after the award date of August 25, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,325.77 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,768.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units). This is a non-set-aside, competitively awarded contract with a completion date of January 7, 2026, and performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $10,092.48 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication commonly used in respiratory disease management. The contract is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $10,077.31 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which is not set-aside, represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to...